Philip Morris pours billions into health care; judge invalidates parts of ACA that mandate coverage of many preventive services and drugs

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by       STAT+: Tobacco giant Philip Morris is investing billions in health care. Critics say it's peddling cures for its own poison By Olivia Goldhill Mike Reddy for STAT Philip Morris, best known for its tobacco products, has been taking over health care companies, an unlikely pivot. Read More Opinion: The FDA needs to be more flexible in assessing treatments for rare diseases, like the one that seemed to help my son By Karen Quandt Maria Fabrizio for STAT Clinical trials for rare diseases can be incredibly valuable. But they can also have devastating limitations. Read More Judge invalidates parts of the ACA that mandate health coverage of many preventive services and drugs By Bob Herman Justin Sullivan/Getty Images A federal judge invalidated parts of the ACA that mandate health insurance companies cover PrEP and other preventive services for free. Read More Sponsor content by 7TH CAR-TCR SUMMIT The Biggest Annual CAR-TCR Meeting is Starting Soon! The 7th CAR-TCR Summit returns to Boston this September 19-22. Join 1,000+ industry attendees to reunite in-person for the first time since 2019. Across 4 days, 200+ CAR and TCR experts will lead 8 streams dedicated to discovery, translation, clinical management, early phase development, manufacturing, CMC/Analytics, logistics and market access. Join your industry to discuss novel allogeneic approaches, the latest in vivo gene engineering techniques, advances in CMC strategies and much more – don't miss out! Register Now. Roche pays $250 million to acquire Good Therapeutics and its preclinical cancer therapy By Damian Garde Good Therapeutics The deal marks an encouraging sign in what remains a difficult market for biotech startups, which have struggled to maintain their valuations. Read More STAT+: UnitedHealth signs a deal with Walmart for a new Medicare Advantage plan By Tara Bannow Megan Thielking/STAT UnitedHealth Group’s deal with Walmart could strengthen its already wide lead in the Medicare Advantage market. Read More Wednesday, September 7, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser